PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33644057-0	2021	Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis.	Cisplatin	0-9	AKT serine/threonine kinase 1	Homo sapiens	134-137	
33644057-0	2021	Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis.	Cisplatin	72-81	AKT serine/threonine kinase 1	Homo sapiens	134-137	
33644057-6	2021	Further mechanism study demonstrated that cisplatin-resistant gastric cancer cell-derived exosomal RPS3 enhanced the chemoresistance of cisplatin-sensitive gastric cancer cells through the PI3K-Akt-cofilin-1 signaling pathway.	Cisplatin	42-51	AKT serine/threonine kinase 1	Homo sapiens	194-197	
33644057-6	2021	Further mechanism study demonstrated that cisplatin-resistant gastric cancer cell-derived exosomal RPS3 enhanced the chemoresistance of cisplatin-sensitive gastric cancer cells through the PI3K-Akt-cofilin-1 signaling pathway.	Cisplatin	136-145	AKT serine/threonine kinase 1	Homo sapiens	194-197	
33644057-7	2021	All these findings demonstrated that cisplatin-resistant gastric cancer cells communicate with sensitive cells through the intercellular delivery of exosomal RPS3 and activation of the PI3K-Akt-cofilin-1 signaling pathway.	Cisplatin	37-46	AKT serine/threonine kinase 1	Homo sapiens	190-193